MedTrace Logo

Performance of an Ultrasensible Malaria Rapid Diagnostic Test Among Pregnant Women in Burkina Faso

NCT06572644 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 288

Last updated 2024-08-28

No results posted yet for this study

Summary

The goal of this observational study is to learn about the diagnostic performance of the highly sensitive rapid diagnostic test (HS-RDT) compared to an ultrasensitive qPCR for detection of falciparum malaria in pregnant women attending antenal care (ANC) in Burkina Faso. The main question it aims to answer is:

• What are the sensitivity and specificity of the HS-RDT compared to ultrasensitive quantitative polymerase chain reaction (qPCR) considered as gold standard for dection of falciparum malaria in pregnant women attending ANC in Burkina Faso ? Participants will be included during their ANC visits and screened for malaria using the HS\_RDT, the conventional RDT (Co\_RDT), microscopy, and qPCR.

Conditions

  • Malaria,Falciparum

Sponsors & Collaborators

  • University of Ghana

    collaborator OTHER

  • Centre MURAZ/Institut National de Santé Publique

    lead OTHER_GOV

Principal Investigators

  • Mamoudou Cissé, MD, PhD · Centre MURAZ/Institut National de Santé Publique

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-11
Primary Completion
2022-12-16
Completion
2023-12-31

Countries

  • Burkina Faso

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06572644 on ClinicalTrials.gov